IO Biotech, Inc.
IOBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $61 | $82 | $66 | $184 |
| - Cash | $60 | $143 | $143 | $212 |
| + Debt | $2 | $2 | $3 | $0 |
| Enterprise Value | $2 | -$59 | -$74 | -$27 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$93 | -$84 | -$69 | -$67 |
| % Margin | – | – | – | – |
| Net Income | -$95 | -$86 | -$71 | -$68 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.45 | -1.98 | -2.48 | -2.36 |
| % Growth | 26.8% | 20.2% | -5.1% | – |
| Operating Cash Flow | -$82 | -$72 | -$60 | -$41 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$82 | -$72 | -$60 | -$41 |